1. Home
  2. PROK vs OWLT Comparison

PROK vs OWLT Comparison

Compare PROK & OWLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROK
  • OWLT
  • Stock Information
  • Founded
  • PROK 2015
  • OWLT 2013
  • Country
  • PROK United States
  • OWLT United States
  • Employees
  • PROK N/A
  • OWLT N/A
  • Industry
  • PROK Biotechnology: Biological Products (No Diagnostic Substances)
  • OWLT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • PROK Health Care
  • OWLT Health Care
  • Exchange
  • PROK Nasdaq
  • OWLT Nasdaq
  • Market Cap
  • PROK 85.5M
  • OWLT 98.3M
  • IPO Year
  • PROK N/A
  • OWLT N/A
  • Fundamental
  • Price
  • PROK $4.74
  • OWLT $8.76
  • Analyst Decision
  • PROK Buy
  • OWLT
  • Analyst Count
  • PROK 4
  • OWLT 0
  • Target Price
  • PROK $5.33
  • OWLT N/A
  • AVG Volume (30 Days)
  • PROK 33.1M
  • OWLT 126.2K
  • Earning Date
  • PROK 08-08-2025
  • OWLT 08-11-2025
  • Dividend Yield
  • PROK N/A
  • OWLT N/A
  • EPS Growth
  • PROK N/A
  • OWLT N/A
  • EPS
  • PROK N/A
  • OWLT N/A
  • Revenue
  • PROK $306,000.00
  • OWLT $84,410,000.00
  • Revenue This Year
  • PROK $54.34
  • OWLT $19.88
  • Revenue Next Year
  • PROK N/A
  • OWLT $23.23
  • P/E Ratio
  • PROK N/A
  • OWLT N/A
  • Revenue Growth
  • PROK N/A
  • OWLT 45.47
  • 52 Week Low
  • PROK $0.46
  • OWLT $2.75
  • 52 Week High
  • PROK $7.13
  • OWLT $9.74
  • Technical
  • Relative Strength Index (RSI)
  • PROK 92.14
  • OWLT 68.30
  • Support Level
  • PROK $0.54
  • OWLT $8.37
  • Resistance Level
  • PROK $7.13
  • OWLT $9.74
  • Average True Range (ATR)
  • PROK 0.62
  • OWLT 0.62
  • MACD
  • PROK 0.47
  • OWLT 0.03
  • Stochastic Oscillator
  • PROK 68.59
  • OWLT 63.77

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

About OWLT Owlet Inc.

Owlet Inc is engaged in providing a digital parenting platform that aims to give parents real-time data and insights to help parents feel more calm and confident. Its diversified portfolio of products includes Owlet Smart Sock, the first baby monitor to track an infant's oxygen levels, heart rate, and sleep trends; the Owlet Cam, which turns any smartphone into a baby monitor with high-definition clarity; the Owlet Monitor Duo, which offers the intelligence of the Owlet Smart Sock paired with the Owlet Cam; and Owlet Dream Lab, an interactive online program designed to be a parent's guide to building healthy sleep habits for their infants.

Share on Social Networks: